Funding Rounds
Netris Pharma

Netris Pharma Series A (2023, $8M)

Netris Pharma

Developer of therapeutic molecules to treat cancer.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $8.24M

Investors